Evidence map›Paper›PMID 20207720›Full record

Trial reportThe Journal of pharmacology and experimental therapeutics2010

Acetaminophen elimination half-life in humans is unaffected by short-term consumption of sulfur amino acid-free diet.

Yanci O Mannery, Thomas R Ziegler, Youngja Park, Dean P Jones

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of pharmacology and experimental therapeutics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Yanci O ManneryGraduate Program in Molecular and Systems Pharmacology, Emory University, Atlanta, Georgia 30322, USA.
Thomas R Ziegler
Youngja Park
Dean P Jones
Pulmonary and Allergy Associates · USEmory University · USUnité de Nutrition Humaine · FR

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025008 · NCRR · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2007 to 2011
$29.0M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
X LINKED NYSTAGMUS SYNDROME WITH FEATURES OF ALBINISMM01RR000039 · NCRR · EMORY UNIVERSITY · PI VACCARINO, VIOLA · 1985 to 2007
$21.3M
Thioredoxin-2 protection against mitochondrial oxidative toxicityR01ES009047 · NIEHS · EMORY UNIVERSITY · PI JONES, DEAN PAUL · 1998 to 2013
$3.9M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalTL1TR000456 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$1.2M
Atlanta Clinical and Translational Science Institute (TL1)TL1RR025010 · NCRR · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2007 to 2011
$1.1M
Patient Oriented Research in Clinical NutritionK24RR023356 · NCRR · EMORY UNIVERSITY · PI ZIEGLER, THOMAS R · 2007 to 2011
$839k
Metabolic analysis in human sulfur amino acid deficiencyR03DK066008 · NIDDK · EMORY UNIVERSITY · PI JONES, DEAN P. · 2004 to 2005
$306k
Metabolic effects of chemical interactions in toxicityR03ES012929 · NIEHS · EMORY UNIVERSITY · PI JONES, DEAN P. · 2004 to 2005
$153k
NCATS NIH HHS TL1 TR000456NCATS NIH HHS UL1 TR000454NCRR NIH HHS K24 RR023356NCRR NIH HHS K24-RR023356NCRR NIH HHS M01-RR00039/UL1 RR025008NCRR NIH HHS TL1 RR025010NCRR NIH HHS TL1-RR025010NCRR NIH HHS UL1 RR025008NIDDK NIH HHS R03 DK066008NIEHS NIH HHS ES009047NIEHS NIH HHS ES012929NIEHS NIH HHS R01 ES009047NIEHS NIH HHS R03 ES012929
6 · The paper itself

Abstract

Sulfation and glutathione (GSH) conjugation are important pathways for elimination of acetaminophen (APAP). Previous studies in rodents show that limitation of dietary sulfur amino acids (SAAs) reduces biosynthesis of 3'-phosphoadenosine-5'-phosphosulfate, the precursor for sulfation, and GSH, the precursor for the mercapturatic acid pathway. The amount of SAA needed for the metabolism of two doses of APAP is equivalent to 62% of the recommended dietary allowance (RDA) for SAA in humans. A decrease in the activity of these metabolic pathways could lead to decreased elimination of the reactive metabolite of APAP and possibly affect risk of APAP use. To determine whether intake of a SAA-deficient diet alters APAP metabolism, a pilot clinical study with a double-blind, cross-over design was performed. Subjects received the RDA for SAA for 3 days for equilibration. After admission to the clinical research unit, subjects were given a chemically defined diet with 100 or 0% of the RDA for SAA for 2 days. On day 3, two doses of APAP (15 mg/kg) or placebo were given successively within a 6-h interval. Plasma samples were collected at baseline and hourly for 12 h, and two 6-h urine aliquots were collected during this time course. The data show that SAA limitation 1) did not change the pattern of APAP metabolites in plasma or urine and 2) did not alter APAP pharmacokinetics. Thus, the results show that 2 days of diet completely devoid of SAA have no effect on APAP metabolism or disposition in healthy humans.

Indexed as

AcetaminophenAdolescentAdultAmino Acids, SulfurAnalgesics, Non-NarcoticArea Under CurveBiotransformationCross-Over StudiesDietDouble-Blind MethodFemaleHalf-LifeHumansMaleYoung AdultAcetaminophenAmino Acids, SulfurAnalgesics, Non-Narcotic

Identifiers

PMID20207720
PMCPMC2879925
OpenAlexW2151591363

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.